Target profiling

Fuzzy fragment-based mapping exploits the fact that when a substantial chemical coverage is available for a given target, key interaction points can be revealed 

The method has been successfully validated retrospectively, on its ability to predict the entire experimental interaction matrix between 13 antipsychotic drugs and 34 protein targets (Box 21.1) [20] and also prospectively on its capacity to correctly anticipate the affinity profile of the drug cyclobenzaprine [21]. 

In silico Identification and In Vitro Confirmation of Novel Targets for PJ34 

---

AstraZeneca (year 2000) Generic lead target profile for progressing HTS hits to leads ... 

The predicted concentration-time profiles for all three formulations are shown in Figure 5 (panel a). These simulations use the fitted in vitro profiles for input to the model. For comparison, the simulations assuming zero order release are shown in panel b. Although the zero order simulations may be useful for initial specification of target profiles, they offer little of value for selecting specific formulations for the in vivo study or for study design (e.g., selection of sampling times),... 

Often the first few pilot PK studies in formulation development are not aimed for the specific purpose of IVIVC. However, it is normally in these first studies that the greatest difference in release rates is seen, before settling on a target profile, making them very valuable for IVIVC development. Prospective inclusion of an appropriate reference formulation can allow these valuable data to be used retrospectively for the purpose of IVIVC. 

Drug development starts with a development plan in which the targeted profile of the compound is de-... 

The duration of the development process, together with the progressive investments required, make it mandatory to have milestones along the way (see Table 3). At these milestones key data are reviewed and a decision taken to continue if the target profile can still be met, or to stop if this is not the case (go/no go decision). In practice the third option i.e. to adapt... 

Needs factors Target profile Functional specification Class comparators Market size/ growth Benefits... 

Sun, C. and Hajduk, P. J. (2006) Nuclear magnetic resonance in target profiling and compound file enhancement. Curr. Opin. Drug Discov. Devet. 9,463-470. 

Keywords Activity-based protein profiling Chemical biology Molecular probes Natural products Target profiling... 

Rix U, Superti-Furga G (2009) Target profiling of small molecules by chemical proteomics. Nat Chem Biol 5 616-624... 

Weljie, A. M., Newton, J., Mercier, P., Carlson, E., and Slupsky, C. M. Targeted profiling Quantitative analysis of XH NMR metabolomics data. Anal. Chem. 78, 4430-4442, 2006. 

Privileged Structures with Undesired Target Profiles 119... 

No clinical candidate molecule ever fulfills all of the drug-target profile requirements in terms of efficacy, safety, or ease of administration originally agreed on by the scientists, clinicians, and marketers. The company is faced with the reality that it has spent a huge amount of money it would love to be in the Alzheimer disease market and the company has to be in... 

TABLE 19.5 Astra-Zeneca Generic Lead Target Profile for Progressing HTS Hits to Leads ... 

After candidate selection, planning for EIH becomes the focal point of the team s efforts with emphasis on development, manufacture, and release of clinical materials. A formal product development team may be formed and a development plan is prepared to define the target profile for the successful candidate and criteria to be used to assess progress toward that profile. 

---